Trial intelligence / Profile preview

High-opioid versus high-hypnotic anesthesia regimens during back surgery

2006-003720-11Phase 4Completed

Sponsor
GE HealthCare
Start
Aug 2006
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of remifentanil and propofol (2 arms), sponsored by GE HealthCare. Primary endpoints: Correlation of stress markers with predicted plasma opioid concentration and Intraoperative stress response at noxious stimuli. Started Aug 2006; status: completed.

02

Drugs

remifentanilpropofol

Beyond the preview

Go deeper on 2006-003720-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003720-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call